Mesa Laboratories, Inc. (MLAB)
127.40
+3.08
(+2.48%)
USD |
NASDAQ |
Aug 25, 16:00
127.40
0.00 (0.00%)
After-Hours: 19:59
Mesa Laboratories EPS Diluted (Quarterly) : 0.4916 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4916 |
| March 31, 2026 | -0.746 |
| December 31, 2025 | 0.6523 |
| September 30, 2025 | 0.4473 |
| June 30, 2025 | 0.854 |
| March 31, 2025 | -1.308 |
| December 31, 2024 | -0.3087 |
| September 30, 2024 | 0.6266 |
| June 30, 2024 | 0.6246 |
| March 31, 2024 | -47.20 |
| December 31, 2023 | 0.3921 |
| September 30, 2023 | -0.2283 |
| June 30, 2023 | -0.1022 |
| March 31, 2023 | 0.1136 |
| December 31, 2022 | 0.0841 |
| September 30, 2022 | 0.2435 |
| June 30, 2022 | -0.2727 |
| March 31, 2022 | -0.3396 |
| December 31, 2021 | -0.3937 |
| September 30, 2021 | 0.6961 |
| June 30, 2021 | 0.3763 |
| March 31, 2021 | 0.7393 |
| December 31, 2020 | -0.8862 |
| September 30, 2020 | 0.5112 |
| June 30, 2020 | 0.2607 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3546 |
| December 31, 2019 | -1.031 |
| September 30, 2019 | 0.7341 |
| June 30, 2019 | 1.125 |
| March 31, 2019 | 0.3437 |
| December 31, 2018 | 0.2121 |
| September 30, 2018 | 0.25 |
| June 30, 2018 | 1.06 |
| March 31, 2018 | 1.08 |
| December 31, 2017 | -2.93 |
| September 30, 2017 | 0.60 |
| June 30, 2017 | 0.39 |
| March 31, 2017 | 0.94 |
| December 31, 2016 | 0.84 |
| September 30, 2016 | 0.62 |
| June 30, 2016 | 0.51 |
| March 31, 2016 | 1.06 |
| December 31, 2015 | 0.69 |
| September 30, 2015 | 0.47 |
| June 30, 2015 | 0.63 |
| March 31, 2015 | 0.61 |
| December 31, 2014 | 0.66 |
| September 30, 2014 | 0.84 |
| June 30, 2014 | 0.51 |
| March 31, 2014 | 0.95 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.198 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Bruker Corp. | -0.413 |
| Danaher Corp. | 1.230 |
| Harvard Bioscience, Inc. | -0.643 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.83M |
| Revenue (Quarterly) | 60.14M |
| Total Expenses (Quarterly) | 57.31M |
| Enterprise Value | 826.33M |
| Gross Profit Margin (Quarterly) | 57.87% |
| Profit Margin (Quarterly) | 4.71% |
| Earnings Yield | 0.66% |
| Operating Earnings Yield | 3.15% |
| Normalized Earnings Yield | 0.6635 |